Published on in Vol 21, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12785, first published .
Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review

Antoine Piau 1, 2, MD, PhD;  Katherine Wild 2, PhD;  Nora Mattek 2, MPH;  Jeffrey Kaye 2, MD

1 Gerontopole, University Hospital of Toulouse, UPS, Toulouse , FR

2 Oregon Center for Aging and Technology (ORCATECH), Oregon Health and Science University , Portland, OR, US

Corresponding Author:

  • Antoine Piau, MD, PhD
  • Oregon Center for Aging and Technology (ORCATECH)
  • Oregon Health and Science University
  • 3181 SW Sam Jackson Park Rd
  • Portland, OR
  • US
  • Phone: 1 971-230-8664
  • Email: antoinepiau@hotmail.com